Sandbox:hudakarman: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) No edit summary |
Hudakarman (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{A}} | {{A}} | ||
{{CMG}} {{hudakarman}} | {{CMG}} {{hudakarman}} | ||
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | {| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | ||
| Line 296: | Line 298: | ||
* | * | ||
|} | |} | ||
CVS | |||
==CVS== | |||
===vsd=== | |||
====ASD==== | |||
Revision as of 18:43, 2 June 2020
Template:A Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Huda A. Karman, M.D.
|
Disease Microchapters |
|
Treatment |
|---|
|
Case Studies |
.................................. ................................ ......................................
| Variant | Associated mutation |
|---|---|
| Variant | Associated mutation |
|---|---|
| A | B |
|---|---|
| C |
|
| E | F |
| |
| H | |
| |
| K | |
| |
| M | |
|
| Disease | Characteristics | Signs and Symptoms | Associated Conditions | Histopathology | Lab finding
& Other evaluation |
Prognosis |
|---|---|---|---|---|---|---|
| A |
|
|
|
|
|
|
CVS
CVS
vsd
ASD
HEM has four main components, Preparedness, response, recovery, and mitigation. When we assess the development, the challenges, the setbacks, and progress of FEMA throughout history, we should look at the big picture and and also at the individual components. 1903: